Back
Vertex Pharmaceuticals Vs. Sarepta Therapeutics Industry Stock Comparison
Buy
62
VRTX
Vertex Pharmaceuticals
Last Price:
500.00
Seasonality Move:
6.39%
Sell
31
SRPT
Sarepta Therapeutics
Last Price:
124.92
Seasonality Move:
11.13%
Buy
62
Vertex Pharmaceuticals (VRTX)
is a Buy
Is Vertex Pharmaceuticals a Buy, Sell or Hold?
- The current Vertex Pharmaceuticals [VRTX] share price is $499.88. The Score for VRTX is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- VRTX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
31
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $125.01. The Score for SRPT is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
- SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
VRTX Stock Price Chart
What is Vertex Pharmaceuticals's stock price today?
-
The Vertex Pharmaceuticals share price today is $499.88
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VRTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $125.01
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.
VRTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.54 | Buy |
| Relative Strength Index (14 RSI): | 64.53 | Buy |
| Chaikin Money Flow: | 1300283 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (462.01 - 484.31) | Buy |
| Bollinger Bands (100): | (466.42 - 489.1) | Buy |
SRPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.16 | Sell |
| Relative Strength Index (14 RSI): | 46.43 | Sell |
| Chaikin Money Flow: | 728345 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (120.8 - 128.94) | Buy |
| Bollinger Bands (100): | (123.42 - 147.2) | Sell |
VRTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 477.49 | Buy |
| 20-day SMA: | 476.96 | Buy |
| 50-day SMA: | 474.11 | Buy |
| 200-day SMA: | 450.92 | Buy |
| 8-day EMA: | 479.73 | Buy |
| 20-day EMA: | 476.22 | Buy |
| 50-day EMA: | 474.52 | Buy |
| 200-day EMA: | 449.21 | Buy |
SRPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 127.08 | Sell |
| 20-day SMA: | 126 | Sell |
| 50-day SMA: | 127.18 | Sell |
| 200-day SMA: | 130.57 | Sell |
| 8-day EMA: | 125.96 | Sell |
| 20-day EMA: | 126.26 | Sell |
| 50-day EMA: | 128.02 | Sell |
| 200-day EMA: | 127.82 | Sell |
Vertex Pharmaceuticals Earnings Growth & VRTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.70 per share, a decrease next quarter of $0.00 per share, a decrease this year of $14.60 per share, and an increase next year of $18.34 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.72 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.19 per share, and an increase next year of $8.77 per share.
Vertex Pharmaceuticals Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Sarepta Therapeutics Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||